Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

330

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 30, 2025

Conditions

Presbyopia

Interventions

DRUG

Pilocarpine HCl Ophthalmic Solution

Pilocarpine HCl ophthalmic solution 1.25%, one drop in each eye, once daily, for up to 30 days

DRUG

Vehicle

Vehicle, one drop in each eye, once daily, for up to 30 days.